Cargando…

Co-incidental increase in gene copy number of ERBB2 and LRIG1 in breast cancer

Detalles Bibliográficos
Autores principales:	Ljuslinder, Ingrid, Golovleva, Irina, Henriksson, Roger, Grankvist, Kjell, Malmer, Beatrice, Hedman, Håkan
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2716489/ https://www.ncbi.nlm.nih.gov/pubmed/19490591 http://dx.doi.org/10.1186/bcr2248

Ejemplares similares

Increased copy number at 3p14 in breast cancer
por: Ljuslinder, Ingrid, et al.
Publicado: (2005)

Correction: Increased copy number at 3p14 in breast cancer
por: Ljuslinder, Ingrid, et al.
Publicado: (2006)

LRIG1 gene copy number analysis by ddPCR and correlations to clinical factors in breast cancer
por: Faraz, Mahmood, et al.
Publicado: (2020)

LRIG and cancer prognosis
por: Lindquist, David, et al.
Publicado: (2014)

Gene expression pattern of the epidermal growth factor receptor family and LRIG1 in renal cell carcinoma
por: Thomasson, Marcus, et al.
Publicado: (2012)

Lrig2-Deficient Mice Are Protected against PDGFB-Induced Glioma
por: Rondahl, Veronica, et al.
Publicado: (2013)

Lrig1 is a haploinsufficient tumor suppressor gene in malignant glioma
por: Mao, Feng, et al.
Publicado: (2018)

A protein interaction network centered on leucine-rich repeats and immunoglobulin-like domains 1 (LRIG1) regulates growth factor receptors
por: Faraz, Mahmood, et al.
Publicado: (2018)

LRIG1 negatively regulates RET mutants and is downregulated in thyroid cancer
por: Lindquist, David, et al.
Publicado: (2018)

LRIG proteins regulate lipid metabolism via BMP signaling and affect the risk of type 2 diabetes
por: Herdenberg, Carl, et al.
Publicado: (2021)

HYPOTHESIS: Do LRIG Proteins Regulate Stem Cell Quiescence by Promoting BMP Signaling?
por: Herdenberg, Carl, et al.
Publicado: (2022)

Expression of LRIG1 is associated with good prognosis and human papillomavirus status in oropharyngeal cancer
por: Lindquist, D, et al.
Publicado: (2014)

Vertebrate Lrig3-ErbB Interactions Occur In Vitro but Are Unlikely to Play a Role in Lrig3-Dependent Inner Ear Morphogenesis
por: Abraira, Victoria E., et al.
Publicado: (2010)

LRIG1 and epidermal growth factor receptor in renal cell carcinoma: a quantitative RT–PCR and immunohistochemical analysis
por: Thomasson, M, et al.
Publicado: (2003)

LRIG1 and epidermal growth factor receptor in renal cell carcinoma: a quantitative RT–RCR and immunohistochemical analysis
por: Thomasson, M, et al.
Publicado: (2004)

Decreased LRIG1 in fulvestrant-treated luminal breast cancer cells permits ErbB3 upregulation and increased growth
por: Morrison, Meghan M., et al.
Publicado: (2015)

Lrig2 and Hpse2, mutated in urofacial syndrome, pattern nerves in the urinary bladder
por: Roberts, Neil A., et al.
Publicado: (2019)

LRIG1 is a conserved EGFR regulator involved in melanoma development, survival and treatment resistance
por: Billing, Ola, et al.
Publicado: (2021)

Lrig1 controls intestinal stem cell homeostasis by negative regulation of ErbB signalling
por: Wong, Vivian W.Y., et al.
Publicado: (2012)

Expression of LRIG proteins as possible prognostic factors in primary vaginal carcinoma
por: Ranhem, Cecilia, et al.
Publicado: (2017)

Mitochondrial DNA copy number instability in ERBB2-amplified breast cancer tumors
por: Ebrahimi, Elmira, et al.
Publicado: (2018)

Mutation analysis and copy number alterations of KIF23 in non-small-cell lung cancer exhibiting KIF23 over-expression
por: Vikberg, Ann-Louise, et al.
Publicado: (2017)

LRIG1 is a triple threat: ERBB negative regulator, intestinal stem cell marker and tumour suppressor
por: Wang, Y, et al.
Publicado: (2013)

DNA methylation and copy number variation profiling of T-cell lymphoblastic leukemia and lymphoma
por: Haider, Zahra, et al.
Publicado: (2020)

The Prognostic and Therapeutic Potential of LRIG3 and Soluble LRIG3 in Glioblastoma
por: Cheng, Fangling, et al.
Publicado: (2019)

Corrigendum: The Prognostic and Therapeutic Potential of LRIG3 and Soluble LRIG3 in Glioblastoma
por: Cheng, Fangling, et al.
Publicado: (2020)

Detection of erbB2 copy number variations in plasma of patients with esophageal carcinoma
por: Andolfo, Immacolata, et al.
Publicado: (2011)

Analysis of copy number loss of the ErbB4 receptor tyrosine kinase in glioblastoma
por: Jones, DeAnalisa C., et al.
Publicado: (2018)

ErbB2 copy number gain is associated with adverse outcome in canine mammary carcinoma
por: SAKAI, Kosei, et al.
Publicado: (2021)

Estimating copy number using next-generation sequencing to determine ERBB2 amplification status
por: Nakamura, Kohei, et al.
Publicado: (2021)

The soluble form of the tumor suppressor Lrig1 potently inhibits in vivo glioma growth irrespective of EGF receptor status
por: Johansson, Mikael, et al.
Publicado: (2013)

Precise ERBB2 copy number assessment in breast cancer by means of molecular inversion probe array analysis
por: Christgen, Matthias, et al.
Publicado: (2016)

LRIG1-2 and LMO7 immunoreactivity in vulvar squamous cell carcinoma: Association with prognosis in relation to HPV-DNA and p16(INK4a) status
por: Stefansson, Kristina, et al.
Publicado: (2019)

The transmembrane protein LRIG2 increases tumor progression in skin carcinogenesis
por: Hoesl, Christine, et al.
Publicado: (2019)

EGFR-activating mutations, DNA copy number abundance of ErbB family, and prognosis in lung adenocarcinoma
por: Chen, Hsuan-Yu, et al.
Publicado: (2016)

Pre-diagnostic serum levels of EGFR and ErbB2 and genetic glioma risk variants: a nested case-control study
por: Späth, Florentin, et al.
Publicado: (2016)

Simultaneous copy number gains of NUPR1 and ERBB2 predicting poor prognosis in early-stage breast cancer
por: Jung, Seung-Hyun, et al.
Publicado: (2012)

Genomic copy number gains of ErbB family members predict poor clinical outcomes in glioma patients
por: Liu, Rui, et al.
Publicado: (2017)

A common copy-number breakpoint of ERBB2 amplification in breast cancer colocalizes with a complex block of segmental duplications
por: Marotta, Michael, et al.
Publicado: (2012)

LRIG1 expression and colorectal cancer prognosis
por: Bakherad, Maryam, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5lm83qjgteo43bcbp52shm51s8